PROFUSA INC (PFSA) Stock Price & Overview
NASDAQ:PFSA • US74319X2071
Current stock price
The current stock price of PFSA is 0.5956 USD. Today PFSA is down by -6.2%. In the past month the price increased by 11.12%.
PFSA Key Statistics
- Market Cap
- 810.016K
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -278.73
- Dividend Yield
- N/A
PFSA Stock Performance
PFSA Stock Chart
PFSA Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to PFSA.
PFSA Earnings
PFSA Forecast & Estimates
PFSA Groups
Sector & Classification
PFSA Financial Highlights
Over the last trailing twelve months PFSA reported a non-GAAP Earnings per Share(EPS) of -278.73. The EPS decreased by -2240.33% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -919.85% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
PFSA Ownership
PFSA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | 41.05 | 170.062B | ||
| ABT | ABBOTT LABORATORIES | 14.72 | 160.7B | ||
| SYK | STRYKER CORP | 21.8 | 126.249B | ||
| BSX | BOSTON SCIENTIFIC CORP | 16.64 | 97.627B | ||
| EW | EDWARDS LIFESCIENCES CORP | 23.63 | 45.962B | ||
| IDXX | IDEXX LABORATORIES INC | 37.88 | 44.549B | ||
| BDX | BECTON DICKINSON AND CO | 11.35 | 44.092B | ||
| RMD | RESMED INC | 17.88 | 31.978B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.52 | 31.89B | ||
| DXCM | DEXCOM INC | 24.65 | 24.131B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.9 | 17.894B | ||
| PODD | INSULET CORP | 29.65 | 13.313B | ||
| PEN | PENUMBRA INC | 65.33 | 13.094B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About PFSA
Company Profile
Profusa Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in New York City, New York and currently employs 0 full-time employees. The company went IPO on 2021-12-20. Profusa, Inc. is a commercial stage digital health company. The firm is engaged in the development of a new generation of biointegrated sensors that potentially empower the individual with the ability to monitor their body chemistry. The Company’s technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. Its first clinical offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels in various regions of interest, both acutely and long-term. The Lumee Oxygen Platform has been designed for use in applications where monitoring of compromised tissue is beneficial, such as peripheral artery disease that results in narrowing of blood vessels and reduced blood flow to the lower limbs; chronic wounds (diabetic ulcers, pressure sores) that do not heal properly; and reconstructive surgery.
Company Info
IPO: 2021-12-20
PROFUSA INC
207 West 25Th St, 9Th Floor
New York City NEW YORK US
Employees: 0
Phone: 12124949022
PROFUSA INC / PFSA FAQ
Can you describe the business of PROFUSA INC?
Profusa Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in New York City, New York and currently employs 0 full-time employees. The company went IPO on 2021-12-20. Profusa, Inc. is a commercial stage digital health company. The firm is engaged in the development of a new generation of biointegrated sensors that potentially empower the individual with the ability to monitor their body chemistry. The Company’s technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. Its first clinical offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels in various regions of interest, both acutely and long-term. The Lumee Oxygen Platform has been designed for use in applications where monitoring of compromised tissue is beneficial, such as peripheral artery disease that results in narrowing of blood vessels and reduced blood flow to the lower limbs; chronic wounds (diabetic ulcers, pressure sores) that do not heal properly; and reconstructive surgery.
What is the current price of PFSA stock?
The current stock price of PFSA is 0.5956 USD. The price decreased by -6.2% in the last trading session.
Does PFSA stock pay dividends?
PFSA does not pay a dividend.
What is the ChartMill technical and fundamental rating of PFSA stock?
PFSA has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
Where is PROFUSA INC (PFSA) stock traded?
PFSA stock is listed on the Nasdaq exchange.
Can you provide the PE ratio for PFSA stock?
PROFUSA INC (PFSA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-278.73).